SEQENS Group services

Technology Transfer. Process Development and Optimization. Enzymatic Process Development. Read more. Highly potent compounds, Steroids and Cytotoxics manufacturing capabilities. Read more. Oligonucleotides. Analytical Methods Development. Synthesis of Impurities and Standards. Potential Genotoxic Impurities Evaluation including High Sensitivity Analytical Methods. Solid State (Polymorphism screening / Salts / Co-Crystals). Read more. Characterization of Physical Properties. Particle Design. Read more. Spray Drying & Bioavailability Enhancing. Read more. Scale Up, Process & Analytical Methods Validation. cGMP Manufacturing - Grams to Multi Ton Scale. APIs, Advanced Drug Intermediates and Key Starting Materials.

Seqens provides GMP testing on Active Pharmaceutical Ingredients (API) and excipients. We have an extensive team focused on the development and clinical phase appropriate validation of sensitive and specific analytical methods. Our analysts work closely with our chemists to develop In Process Control, isolated intermediate, and finish product release and stability indicating methods.

Seqens is a world leader in pharmaceutical synthesis, capable of providing full CMC support to prepare for phase III clinical trials and drug registration globally in total compliance with the strictest regulatory, quality and EHS standards.